Qube Research & Technologies (QRT)’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
IWS
Qube Research & Technologies (QRT)'s IHE Position: Q2 2026 in Review
Qube Research & Technologies (QRT) reduced its iShares US Pharmaceuticals ETF (IHE) stake by 39% in Q2 2026, selling an estimated $13.2K and leaving 231 shares worth $22.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3213.
Qube Research & Technologies (QRT) first reported a position in IHE in Q2 2021 and has held it in 16 quarters since. The position peaked at $257K in Q3 2022. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.
- Qube Research & Technologies (QRT) held 231 shares of iShares US Pharmaceuticals ETF worth $22.9K as of Q2 2026.
- Qube Research & Technologies (QRT) sold 147 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $13.2K.
- iShares US Pharmaceuticals ETF made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3213 holding.
- Qube Research & Technologies (QRT) first reported a position in iShares US Pharmaceuticals ETF in Q2 2021 and has held it in 16 quarters since.
- Qube Research & Technologies (QRT)'s iShares US Pharmaceuticals ETF position peaked at $257K in Q3 2022.
- 210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.